Authors:
Oberfield, JL
Collins, JL
Holmes, CP
Goreham, DM
Cooper, JP
Cobb, JE
Lenhard, JM
Hull-Ryde, EA
Mohr, CP
Blanchard, SG
Parks, DJ
Moore, LB
Lehmann, JM
Plunket, K
Miller, AB
Milburn, MV
Kliewer, SA
Willson, TM
Citation: Jl. Oberfield et al., A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiation, P NAS US, 96(11), 1999, pp. 6102-6106
Authors:
Brown, KK
Henke, BR
Blanchard, SG
Cobb, JE
Mook, R
Kaldor, I
Kliewer, SA
Lehmann, JM
Lenhard, JM
Harrington, WW
Novak, PJ
Faison, W
Binz, JG
Hashim, MA
Oliver, WO
Brown, HR
Parks, DJ
Plunket, KD
Tong, WQ
Menius, JA
Adkison, K
Noble, SA
Willson, TM
Citation: Kk. Brown et al., A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat, DIABETES, 48(7), 1999, pp. 1415-1424
Authors:
Henke, BR
Blanchard, SG
Brackeen, MF
Brown, KK
Cobb, JE
Collins, JL
Harrington, WW
Hashim, MA
Hull-Ryde, EA
Kaldor, I
Kliewer, SA
Lake, DH
Leesnitzer, LM
Lehmann, JM
Lenhard, JM
Orband-Miller, LA
Miller, JF
Mook, RA
Noble, SA
Oliver, W
Parks, DJ
Plunket, KD
Szewczyk, JR
Willson, TM
Citation: Br. Henke et al., N-(2-benzoylphenyl)-L-tyrosine PPAR gamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents, J MED CHEM, 41(25), 1998, pp. 5020-5036
Authors:
Collins, JL
Blanchard, SG
Boswell, GE
Charifson, PS
Cobb, JE
Henke, BR
Hull-Ryde, EA
Kazmierski, WM
Lake, DH
Leesnitzer, LM
Lehmann, J
Lenhard, JM
Orband-Miller, LA
Gray-Nunez, Y
Parks, DJ
Plunkett, KD
Tong, WQ
Citation: Jl. Collins et al., N-(2-benzoylphenyl)-L-tyrosine PPAR gamma agonists. 2. Structure-activity relationship and optimization of the phenyl alkyl ether moiety, J MED CHEM, 41(25), 1998, pp. 5037-5054
Authors:
Cobb, JE
Blanchard, SG
Boswell, EG
Brown, KK
Charifson, PS
Cooper, JP
Collins, JL
Dezube, M
Henke, BR
Hull-Ryde, EA
Lake, DH
Lenhard, JM
Oliver, W
Oplinger, J
Pentti, M
Parks, DJ
Plunket, KD
Tong, WQ
Citation: Je. Cobb et al., N-(2-benzoylphenyl)-L-tyrosine PPAR gamma agonists. 3. Structure-activity relationship and optimization of the N-aryl substituent, J MED CHEM, 41(25), 1998, pp. 5055-5069